5,995 Shares in McKesson Corporation $MCK Acquired by Cetera Trust Company N.A

Cetera Trust Company N.A bought a new stake in McKesson Corporation (NYSE:MCK) during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 5,995 shares of the company’s stock, valued at approximately $4,530,000. McKesson makes up approximately 2.3% of Cetera Trust Company N.A’s investment portfolio, making the stock its 7th largest holding.

Several other large investors have also made changes to their positions in MCK. Aberdeen Wealth Management LLC acquired a new position in McKesson in the second quarter valued at about $189,000. Visionary Wealth Advisors bought a new stake in McKesson during the second quarter worth about $341,000. Asset One Wealth Management LLC acquired a new stake in shares of McKesson during the second quarter worth approximately $208,000. Investor s Fiduciary Advisor Network LLC acquired a new stake in shares of McKesson during the second quarter worth approximately $299,000. Finally, Cibc World Market Inc. bought a new position in shares of McKesson in the second quarter valued at approximately $39,617,000. Institutional investors own 85.07% of the company’s stock.

Insider Transactions at McKesson

In other McKesson news, CAO Napoleon B. Rutledge, Jr. sold 133 shares of the business’s stock in a transaction dated Friday, June 5th. The stock was sold at an average price of $764.00, for a total transaction of $101,612.00. Following the completion of the sale, the chief accounting officer directly owned 632 shares of the company’s stock, valued at approximately $482,848. The trade was a 17.39% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Brian S. Tyler sold 8,463 shares of the company’s stock in a transaction dated Tuesday, July 7th. The shares were sold at an average price of $793.56, for a total transaction of $6,715,898.28. Following the transaction, the chief executive officer owned 5,919 shares in the company, valued at approximately $4,697,081.64. The trade was a 58.84% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 23,111 shares of company stock valued at $18,011,274 in the last three months. Company insiders own 0.06% of the company’s stock.

McKesson Stock Performance

NYSE:MCK opened at $874.20 on Tuesday. The company has a market cap of $101.92 billion, a price-to-earnings ratio of 23.39, a P/E/G ratio of 1.69 and a beta of 0.30. The stock’s fifty day moving average price is $822.86 and its two-hundred day moving average price is $844.00. McKesson Corporation has a 52-week low of $673.38 and a 52-week high of $999.00.

McKesson (NYSE:MCK) last released its earnings results on Wednesday, August 5th. The company reported $9.93 EPS for the quarter, beating the consensus estimate of $9.56 by $0.37. The company had revenue of $105.38 billion during the quarter, compared to analysts’ expectations of $103.88 billion. McKesson had a negative return on equity of 253.21% and a net margin of 1.12%.The business’s revenue for the quarter was up 7.7% on a year-over-year basis. During the same period last year, the firm earned $8.26 EPS. McKesson has set its FY 2027 guidance at 44.200-45.000 EPS. On average, equities analysts predict that McKesson Corporation will post 44.65 EPS for the current fiscal year.

McKesson Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 1st. Investors of record on Tuesday, September 1st will be given a $0.94 dividend. The ex-dividend date is Tuesday, September 1st. This is a positive change from McKesson’s previous quarterly dividend of $0.82. This represents a $3.76 dividend on an annualized basis and a yield of 0.4%. McKesson’s dividend payout ratio is 8.78%.

Analysts Set New Price Targets

MCK has been the subject of several research analyst reports. Robert W. Baird set a $1,015.00 price objective on McKesson in a research report on Thursday, August 6th. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $875.00 target price on shares of McKesson in a report on Friday, May 8th. Citigroup raised their target price on McKesson from $945.00 to $1,000.00 and gave the company a “buy” rating in a research note on Friday, July 24th. Morgan Stanley reaffirmed an “overweight” rating on shares of McKesson in a report on Friday, August 7th. Finally, Wells Fargo & Company upped their price target on shares of McKesson from $812.00 to $933.00 and gave the stock an “equal weight” rating in a research report on Tuesday, August 11th. Fourteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $973.44.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.